SL
Sudan Loganathan Stephens & Co. Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Nurix Therapeutics
NRIX
$758M
| $9.91 | $30 |
203%
upside
| Overweight |
10 Jul ‘25
1 month ago |
|
2
Exelixis
EXEL
$10.2B
| $37.88 | $60 |
58%
upside
| Overweight |
24 Jun ‘25
2 months ago |
|
3
Delcath Systems
DCTH
$408M
| $11.65 | $25 |
115%
upside
| Overweight |
23 Jun ‘25
2 months ago |
|
4
Immunome
IMNM
$916M
| $10.52 | $30 |
185%
upside
| Overweight |
20 Mar ‘25
5 months ago |
|
5
Catalyst Pharmaceutical
CPRX
$2.48B
| $20.29 | $33 |
63%
upside
| Overweight |
27 Feb ‘25
6 months ago |
|
6
ADC Therapeutics
ADCT
$398M
| $3.54 | $8 |
126%
upside
| Overweight |
24 Feb ‘25
6 months ago |
|
7
IDEAYA Biosciences
IDYA
$2.38B
| $27.16 | $50 |
84%
upside
| Overweight |
14 Feb ‘25
6 months ago |
|
|
BCYC
8
Bicycle Therapeutics
BCYC
$496M
| $7.16 | $15 |
110%
upside
| Equal-Weight |
22 Jan ‘25
7 months ago |
|
9
Kymera Therapeutics
KYMR
$3.11B
| $43.51 | $60 |
38%
upside
| Overweight |
21 Jan ‘25
7 months ago |
|
10
Actinium Pharmaceuticals
ATNM
$49.3M
| $1.58 | $5 |
216%
upside
| Overweight |
19 Nov ‘24
9 months ago |
|
11
C4 Therapeutics
CCCC
$194M
| $2.72 | $4 |
47%
upside
| Equal-Weight |
18 Nov ‘24
9 months ago |
|
12
Arvinas
ARVN
$575M
| $7.83 | $55 |
602%
upside
| Overweight |
18 Nov ‘24
9 months ago |
|
13
Pyxis Oncology
PYXS
$118M
| $1.91 | $13 |
581%
upside
| Overweight |
8 Nov ‘24
10 months ago |
|
14
Sensei Biotherapeutics
SNSE
$10.5M
| $8.32 | $100 |
1,102%
upside
| Overweight |
24 May ‘24
1 year ago |
|
15
Inovio Pharmaceuticals
INO
$148M
| $2.79 | $20 |
617%
upside
| Overweight |
14 May ‘24
1 year ago |
|